(FEBRUARY 7, 2023) Results of a study by Margaret Infeld, M.D., clinical cardiac electrophysiology fellow and clinical instructor in the Department of Medicine; cardiologist Markus Meyer, M.D., Ph.D., adjunct associate professor of medicine; and colleagues support heart rate modulation as a therapeutic intervention in HFpEF, according to HealthDay News.
Margaret Infeld, M.D. (left) and Markus Meyer, M.D., Ph.D.
(FEBRUARY 7, 2023) Results of a study by Margaret Infeld, M.D., clinical cardiac electrophysiology fellow and clinical instructor in the Department of Medicine; cardiologist Markus Meyer, M.D., Ph.D., adjunct associate professor of medicine; and colleagues support the concept of heart rate modulation as a therapeutic intervention in heart failure with preserved ejection fraction (HFpEF) and provide additional evidence that moderately higher, and not lower, heart rates are beneficial in this patient population, according to HealthDay News. The research was published in JAMA Cardiology.
This research was also featured in a story that aired on CBS3.
Read full story
at
HealthDay News